Monogram Orthopaedics (NASDAQ:MGRM) Announces Earnings Results

Monogram Orthopaedics (NASDAQ:MGRM) issued its quarterly earnings data on Wednesday. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.03, Zacks reports.

Monogram Orthopaedics Stock Up 2.2 %

Shares of Monogram Orthopaedics stock traded up $0.05 during mid-day trading on Wednesday, reaching $2.32. 42,956 shares of the stock traded hands, compared to its average volume of 142,773. The stock has a market capitalization of $79.60 million, a PE ratio of -4.94 and a beta of 1.66. The business has a 50-day moving average of $2.54 and a 200 day moving average of $2.50. Monogram Orthopaedics has a fifty-two week low of $1.53 and a fifty-two week high of $4.90.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on MGRM shares. Roth Capital raised shares of Monogram Orthopaedics to a “strong-buy” rating in a research note on Monday, December 9th. Roth Mkm started coverage on shares of Monogram Orthopaedics in a report on Monday, December 9th. They set a “buy” rating and a $4.00 price objective on the stock.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.